companies innovating in obesity treatment glp-1 drugs 2025 Agonists Weight Loss Market Report, 2025-2030 How to Invest in GLP-1

Metsera, launched in 2022, was developing a once-monthly GLP-1 injectable

Critical nodes in signalling pathways: Insights into insulin action

Effects of once-weekly semaglutide on kidney disease outcomes by KDIGO risk category in the SUSTAIN 6 trial

doi: 10.1038/s41366-020-0535-5 79

Although the exact etiology remains unclear, both UC and CD are thought to result from uncontrolled inflammation and immune dysregulation in genetically predisposed individuals [213]

GLP-1 medications work by mimicking the actions of your natural GLP-1, binding to cells throughout your body that have GLP-1 receptors, and ultimately lowering blood sugar